JBM (Healthcare) (HKSE:02161) Days Sales Outstanding : 50.72 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is JBM (Healthcare) Days Sales Outstanding?

JBM (Healthcare)'s average Accounts Receivable for the six months ended in Sep. 2024 was HK$110.9 Mil. JBM (Healthcare)'s Revenue for the six months ended in Sep. 2024 was HK$399.0 Mil. Hence, JBM (Healthcare)'s Days Sales Outstanding for the six months ended in Sep. 2024 was 50.72.

The historical rank and industry rank for JBM (Healthcare)'s Days Sales Outstanding or its related term are showing as below:

HKSE:02161' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.39 Med: 65.15 Max: 117.71
Current: 67.13

During the past 7 years, JBM (Healthcare)'s highest Days Sales Outstanding was 117.71. The lowest was 52.39. And the median was 65.15.

HKSE:02161's Days Sales Outstanding is ranked better than
56.11% of 957 companies
in the Drug Manufacturers industry
Industry Median: 72.09 vs HKSE:02161: 67.13

JBM (Healthcare)'s Days Sales Outstanding declined from Sep. 2023 (79.98) to Sep. 2024 (50.72).

JBM (Healthcare) Days Sales Outstanding Historical Data

The historical data trend for JBM (Healthcare)'s Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JBM (Healthcare) Days Sales Outstanding Chart

JBM (Healthcare) Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

65.15

94.63

117.71

83.76

61.01

JBM (Healthcare) Semi-Annual Data
	Mar18	Mar19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial							96.25	74.79	79.98	79.99	50.72

Competitive Comparison of JBM (Healthcare)'s Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, JBM (Healthcare)'s Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JBM (Healthcare)'s Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JBM (Healthcare)'s Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where JBM (Healthcare)'s Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

JBM (Healthcare) Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

JBM (Healthcare)'s Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (110.656	+	106.114)	/	2 )	/	648.415	*	365
=	108.385					/	648.415	*	365
=	61.01

JBM (Healthcare)'s Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (106.114	+	115.65)	/	2 )	/	398.953	*	365 / 2
=	110.882					/	398.953	*	365 / 2
=	50.72

JBM (Healthcare) (HKSE:02161) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

JBM (Healthcare) Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of JBM (Healthcare)'s Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

JBM (Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JBM (Healthcare) Ltd (HKSE:02161) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

108 Wai Yip Street, Units 808-811, 8 floor, C-Bons International Centre, Kwun Tong, Kowloon, Hong Kong, HKG

Website

https://www.jbmhealthcare.com.hk

JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.

Executives

Sum Kwong Yip, Derek
Queenshill Development Limited
Ubs Trustees (b.v.i.) Limited
Kingshill Development Group Inc
Lincoln's Hill Development Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si
New Heritage Healthcare Limited	2101 Beneficial owner
Gavett Limited	2201 Interest of corporation controlled by you
United Islands Group Limited	2201 Interest of corporation controlled by you
Fortstar Limited	2201 Interest of corporation controlled by you
Tao Richard	2201 Interest of corporation controlled by you
Hon Hing Tong Patricia	2202 Interest of your spouse
Tao Paul	2201 Interest of corporation controlled by you
Choi Siu Ping	2202 Interest of your spouse
Longjin Investments Limited	2101 Beneficial owner

JBM (Healthcare) Headlines

No Headlines